Reply to Piehler et al.: Depression Symptoms in Patients with Cystic Fibrosis Fluctuate at Baseline and Improve with Elexacaftor/Tezacaftor/Ivacaftor Therapy. [PDF]
Am J Respir Crit Care MedDuff AJA, Lee TWR.
europepmc +1 more source
Impact of Elexacaftor-Tezacaftor-Ivacaftor on Gastrointestinal Symptoms, Intestinal Ultrasound, and Pancreatic Stiffness in Cystic Fibrosis. [PDF]
Clin Transl GastroenterolFraquelli M +5 more
europepmc +1 more source
THE ENZYMATIC CONJUGATION OF m-AMINOPHENOL
Journal of Biological Chemistry, 1952 S, BERNSTEIN, R W, MCGILVERY
openaire +2 more sources
Assessment of efficacy and tolerability of elexacaftor-tezacaftor-ivacaftor in an observational cohort study of "aged" people with cystic fibrosis. [PDF]
Ther Adv Respir DisBlankenship S +6 more
europepmc +1 more source
Merging Excited-State Copper Catalysis and Triplet Nitro(hetero)arenes for Direct Synthesis of 2-Aminophenol Derivatives. [PDF]
ChemShah JA +3 more
europepmc +1 more source
Home-based sleep monitoring using a novel non-contact, radar-based biomotion sensor in adults with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor. [PDF]
Sleep BreathDietz-Terjung S +10 more
europepmc +1 more source
Effects of cAMP and CFTR modulation on apical fluid pH in human airway Calu-3 cells. [PDF]
Physiol RepNguyen JP, Milad N, Hirota JA.
europepmc +1 more source
Phosphatidylserine liposomes for <i>Mycobacterium abscessus</i> infections management in people with cystic fibrosis non-eligible for CFTR modulators. [PDF]
Front ImmunolOlimpieri T +9 more
europepmc +1 more source
Methods of Analysis for P-Aminophenol, P-Methylaminophenol, and O-Aminophenol
Journal of AOAC INTERNATIONAL, 1940 openaire +1 more source
Impact of elexacaftor/tezacaftor/ivacaftor on the small airways in cystic fibrosis. [PDF]
J Bras PneumolSilva SC +4 more
europepmc +1 more source